Context Therapeutics (CNTX) Stock: Buy, Sell, or Hold?
CNTX - Context Therapeutics Inc. Common Stock
$0.37
0.01 (1.77%)
▲
5d:
+6.72%
30d:
-27.92%
90d:
-40.53%
HOLD
LOW Confidence
Analysis Updated: Sep 21, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When CNTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CNTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CNTX is currently trading at $0.37, which is considered slightly low relative to its 30-day fair value range of $0.36 to $0.48.
Technical Outlook: Technically, CNTX is in a strong downtrend. Immediate support is located at $0.34, while resistance sits at $0.40.
Market Sentiment: CNTX scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.25 (+1034.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNTX is in a strong downtrend. Immediate support is located at $0.34, while resistance sits at $0.40.
Market Sentiment: CNTX scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.25 (+1034.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.36 -
$0.48
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1034.8% below Wall St target ($4.25)
- CAUTION: Bottoming setup, but lagging the sector by 31% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.36 -
$0.48
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.34
Resistance Level
$0.40
Current Trend
Strong Downtrend
Technical data as of
Sep 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.86
Wall Street Target
$4.25
(+1034.8%)
Share & Embed Analysis
Last updated: September 22, 2026 12:41 AM ET
Data refreshes hourly during market hours. Next update: 1:41 AM
Data refreshes hourly during market hours. Next update: 1:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 49 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$849 | 55 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$291 | 55 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 50 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$34 | 63 BUY |
